# Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension

Study · id `cardio:ct-nct01850901` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01850901](<https://clinicaltrials.gov/study/NCT01850901>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01850901

Browse, organ or system: Blood vessels; Kidneys  
Browse, condition area: High blood pressure; Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.

## Technical summary

Registry record NCT01850901. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2016-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 139 participants (enrolled count; ClinicalTrials.gov record NCT01850901, source copy `cardio:ctgov-nct01850901-2017-02-01`, retrieved 2026-10-26)
- Start date: 2013-05 (registry gives no type) (ClinicalTrials.gov record NCT01850901, source copy `cardio:ctgov-nct01850901-2017-02-01`, retrieved 2026-10-26)
- Primary completion: 2016-07 (actual) (ClinicalTrials.gov record NCT01850901, source copy `cardio:ctgov-nct01850901-2017-02-01`, retrieved 2026-10-26)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT01850901, source copy `cardio:ctgov-nct01850901-2017-02-01`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT01850901, source copy `cardio:ctgov-nct01850901-2017-02-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01850901-2017-02-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
- Acronym: SYMPATHY
- Condition: Hypertension
- Condition: Chronic Kidney Disease
- Intervention (Procedure): Renal sympathetic denervation
- Lead sponsor: UMC Utrecht
- Lead sponsor class: OTHER
- Collaborator: ZonMw: The Netherlands Organisation for Health Research and Development
- Collaborator class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Resistant hypertension (`cardio:resistant-hypertension`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: UMC Utrecht (`cardio:org-umc-utrecht`)
- Registry lists this organization as a collaborator: ZonMw: The Netherlands Organisation for Health Research and Development (`cardio:org-zonmw-the-netherlands-organisation-for-health-research-and-cc2e75`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial (`cardio:pubmed-28264922`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f7ce3d49f5b6a86c760bf1b9b7e3de12394e3134cb09f83d9afa551de2df9568
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
